Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports

    The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.
    NYT > Health

    Leave a Reply

    Your email address will not be published. Required fields are marked *